# Surgeon Infiltration QL Block Comparison

> **NCT03496610** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 44 (actual)

## Conditions studied

- Quadratus Lumborum Block
- Surgical Wound Infiltration

## Interventions

- **DRUG:** Liposomal Bupivicaine
- **PROCEDURE:** QL Block

## Key facts

- **NCT ID:** NCT03496610
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-25
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-02-23
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03496610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03496610, "Surgeon Infiltration QL Block Comparison". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03496610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*